Pyxis Oncology, Inc. (PYXS)

1.105 +0.02 (+1.38%) USD  |  NASDAQ  |  Dec 24, 12:59
1.11 0.00 (0.00%) After-Hours: 13:59
More

Pyxis Oncology SG&A Expense (TTM): 22.04M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for PYXS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Plus Therapeutics, Inc. 11.09M
Pfizer Inc. 13.91B
Ironwood Pharmaceuticals, Inc. 96.29M
Akebia Therapeutics, Inc. 112.54M
Xtant Medical Holdings, Inc. 74.03M